Press Releases
Particle Works offers bespoke microencapsulation for drug development
Particle Works – the nano- and microstructured material specialist – provides microencapsulation services for drug development applications, including controlled drug release, solubility enhancement or targeted drug delivery. Using its expertise in microfluidics and nanoparticle synthesis, the...
Press Releases
WuXi AppTec Unveils Manufacturing Center for Cutting Edge Cell and Gene Therapies
WuXi AppTec a leading pharmaceutical, biotechnology, and medical device technology platform company, celebrated the grand opening of their new 150,000 square foot bio manufacturing facility in an event attended by Pennsylvania Lieutenant Governor Mike Stack and WuXi AppTec Chairman...
Press Releases
Orexo receives US FDA approval for low dosages of Zubsolv to treat opioid dependence
Orexo AB announced that it has received approval from the US FDA of a new unique low dose, 0.7mg/0.18 mg, tablet of Zubsolv (buprenorphine/naloxone) sublingual tablet (CIII) for the treatment of opioid dependence. The new dosage is expected to...
Press Releases
MEDICAL MANUFACTURING ASIA 2016: Positive showing with top quality prospects
MEDICAL MANUFACTURING ASIA 2016 closed on 2 September to a positive note of 5,200 quality trade visitors from 38 countries, with more than 30% coming from overseas. The importance of MEDICAL MANUFACTURING ASIA 2016 as an...
Press Releases
3M Launches World’s First Tablet-Based Mobile Intraoral Scanner
Mobile tablets, commonplace in many aspects of clinical practice in health care settings, have arrived in the dental industry with the introduction of the 3M™ Mobile True Definition Scanner , a one-of-a-kind tablet-based intraoral scanner that fits in your...
Press Releases
Analytica Anacon India and India Lab Expo 2016
The ninth annual edition of analytica Anacon India and India Lab Expo, India’s leading trade fairs for the laboratory technology, analysis, biotechnology and diagnostics market, take place from October 20 to 22, 2016 at the HITEX Exhibition Centre in...
Press Releases
Roche says first phase III data on tecentriq to feature at the ESMO Congress
Roche announced that new results from studies with its approved or investigational medicines across more than 20 cancer types will be presented during the European Society for Medical Oncology (ESMO) Congress from 7 – 11 October 2016 in Copenhagen,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read